Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2020 | Future of genomics in breast cancer care

Andrew McKenzie and Emma Sturgill, PhD, Sarah Cannon Research Institute, Nashville, TN, outline future advances in the care of patients with breast cancer, including increased use of next-generation sequencing in precision medicine, liquid biopsies and the importance of genomics for the development of new targeted therapies. Dr Sturgill discusses triple-negative breast cancer and the role of genomics in this patient population who have historically exhibited a poorer prognosis. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).